# Electrosclerotherapy for Capillary Malformations

> **NCT02883023** · PHASE2 · UNKNOWN · sponsor: **Sophie Horbach** · enrollment: 20 (estimated)

## Conditions studied

- Capillary Malformations
- Vascular Malformations

## Interventions

- **OTHER:** Electrosclerotherapy
- **DRUG:** Intralesional bleomycin injection

## Key facts

- **NCT ID:** NCT02883023
- **Lead sponsor:** Sophie Horbach
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2018-01
- **Final completion:** 2018-03
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2017-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02883023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02883023, "Electrosclerotherapy for Capillary Malformations". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02883023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*